Phase II study of anlotinib plus sintlimab as second-line treatment for patients with advanced biliary tract cancers.

Published 2021 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Phase II study of anlotinib plus sintlimab as second-line treatment for patients with advanced biliary tract cancers.
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 39, Issue 3_suppl, Pages 307-307
Publisher
American Society of Clinical Oncology (ASCO)
Online
2021-01-23
DOI
10.1200/jco.2021.39.3_suppl.307

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.